| Cat.No. | Name | Information |
|---|---|---|
| M10249 | Teduglutide | Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue used for the treatment of short-bowel syndrome. |
| M10044 | Albiglutide | Albiglutide is a recombinant fusion protein consisting of two copies of a 30-amino-acid sequence of modified human GLP-1 (fragment 7-36), modified with a glycine substituted for the naturally occurring alanine at position 8 in order to augment resistance to DPP-4. |
| M10035 | Semaglutide | Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217) is a long-acting human GLP-1 analog, it is also a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM). |
| M10034 | Exendin-4 | Exenatide (AC2993) is a first-in-class glucagon-like peptide 1 (GLP-1) receptor agonist consisting of 39 amino acids. |
| M9749 | Cotadutide acetate | Cotadutide acetate is a potent peptide dual agonist of glucagon-like peptide-1 (GLP-1) and glucagon receptor, with EC50 values of 6.9 pM and 10.2 pM, respectively. |
| M9488 | Tirzepatide TFA | Tirzepatide (LY3298176) TFA is a first-in-class glucose-dependent insulin stimulating polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) agonist for diabetes research. |
| M9487 | Tirzepatide hydrochloride | Tirzepatide Hydrochloride is a first-in-class glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for the study of diabetes mellitus. |
| M9190 | Lixisenatide | Lixisenatide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which is a hormone that helps normalize blood sugar levels. |
| M8394 | BETP | BETP is an agonist of glucagon-like peptide-1 (GLP-1) receptor, with EC50s of 0.66 and 0.755 μM for human and rat GLP-1 receptor, respectively. |
| M4344 | Shanzhiside-methylester | Shanzhiside Methyl ester was isolated from Lactobacillus rotaformis. Shanzhiside Methyl ester, a small molecule glucagon-like peptide 1 (GLP-1 receptor) agonist, has the ability to induce anti-abnormal pain tolerance. |
| M1601 | Dulaglutide (Activated main chain) | Dulaglutide (Activated main chain) is a glucagon-like peptide-1 receptor agonist (GLP-1 agonist) consisting of GLP-1(7-37) covalently linked to an Fc fragment of human IgG4. |
| M54686 | Amycretin | Amycretin is a novel, potentially first-in-class, long-acting co-agonist of GLP-1 and the amyloid receptor (AMYR) for obesity-related studies. |
| M54605 | NM-003 | NM-003 is a GLP-2R agonist that can be used in studies related to inflammatory bowel disease. |
| M54604 | NB-1002 | NB-1002 is a GLP-2R agonist that can be used in studies related to short bowel syndrome. |
| M54603 | MOD-15014 | MOD-15014 is a GLP-2R modulator that can be used in studies related to short bowel syndrome. |
| M54602 | HM-15912 | HM-15912 is a GLP-2R agonist that can be used in studies related to short bowel syndrome. |
| M54601 | GX-G8 | GX-G8 is a GLP-2R agonist that can be used in studies related to short bowel syndrome. |
| M54600 | PE-0503 | PE-0503 is a fusion protein and a GLP-2R agonist that can be used in studies related to Crohn's disease and short bowel syndrome. |
| M54599 | SHP-681 | SHP-681 is a GLP-2R modulator that can be used in studies related to short bowel syndrome. |
| M54598 | CLF-065 | CLF-065 is a GLP-2R agonist that can be used in studies related to inflammatory bowel disease (IBD). |
| M54597 | Glepaglutide acetate | Glepaglutide acetate is a long-acting GLP-2 analog and a potent GLP-2R agonist.Glepaglutide acetate is used in studies related to inflammatory bowel disease (IBD) and Crohn's disease. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
